St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus
Scientists at St. Jude Children's Research Hospital are tackling Mycobacterium abscessus (Mab) antibiotic resistance.
Stay updated with breaking news from Athogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at St. Jude Children's Research Hospital are tackling Mycobacterium abscessus (Mab) antibiotic resistance.
Recent research suggests that the emergence of tuberculosis infection in human populations dates back tens of thousands of years earlier than previously known cases in the Middle East.
Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.
The temperature-sensitive pathogens that caught U.S. communities off guard are a grim preview of the future.
The R21/Matrix-M™ malaria vaccine is one step closer to mass rollout, after officially receiving WHO prequalification status, making it eligible for procurement by United Nations agencies.